NSE filing, NSE: AKG. Summary written from the filing by ALFA Finder's alert engine.
AKG Exim Ltd: key numbers
- Share price
- ₹9.21
- Market cap
- ₹29.27 Cr
- Revenue (annual)
- ₹87.01 Cr
- Net profit (annual)
- ₹0.36 Cr
- P/E (TTM)
- 78.6×Sector 43.1×
- Promoter holding
- 50.69%+0.00% QoQ
- FII holding
- 1.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AKG Exim Ltd
All →AKG Exim Annual General Meeting
AKG Exim Limited conducted its 21st Annual General Meeting on September 26, 2026. Shareholders transacted seven agenda items, including financial statement adoption and director appointments.
AKG Exim Promoter Selling (Off-Market): ₹9.54 Cr
AKG Exim Limited promoter Mahima Goel sold a 23.10% stake to Kalapi Vinit Nagada via an off-market SPA. The transaction was completed for a consideration of Rs. 9.54 Crore.
- Value
- ₹9.54 Cr
AKG Exim Annual General Meeting
Akg Exim Limited has issued the notice for its 21st Annual General Meeting to be held on September 26, 2026. Agenda items include director appointments and financial adoption.
AKG Exim Management Change
AKG Exim Limited has appointed Mr. Ajay Kumar Prajapati as the Secretarial Auditor of the Company, effective August 12, 2026.
AKG Exim Other Announcement
Akg Exim Limited has appointed M/s APK & Associates as the new Secretarial Auditor to fill a casual vacancy, following the demise of the previous auditor.
AKG Exim Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
AKG Exim Ltd reported revenue from operations of ₹20.7 Cr (-27.6% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Other board meeting date announcements
All →Chordia Food Products Board Meeting Date
Chordia Food Products will hold a board meeting on 3 November 2026. It will consider unaudited financial results for the quarter and half-year ended 30 September 2026.
Orient Ceratech Board Meeting Date
Orient Ceratech has intimated a Board meeting scheduled for 4 November 2026. The agenda includes considering unaudited standalone and consolidated results for Q2 and H1 FY27.
Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.